Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “KRAS Gene Mutation Negative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01202409
What this trial is testing

CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater

Who this might be right for
Gastrointestinal Cancer
M.D. Anderson Cancer Center 19
Early research (Phase 1)Ended earlyNCT01871311
What this trial is testing

A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck Cancer
Georgetown University 15
Large-scale testing (Phase 3)Study completedNCT01001377
What this trial is testing

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,010
Testing effectiveness (Phase 2)Ended earlyNCT01504477
What this trial is testing

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Georgetown University 6
Large-scale testing (Phase 3)Looking for participantsNCT06072781
What this trial is testing

Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

Who this might be right for
Low Grade Serous Ovarian Cancer
Verastem, Inc. 270
Testing effectiveness (Phase 2)Ended earlyNCT01522612
What this trial is testing

Colorectal Cancer (CRC) Cetuximab Elderly Frail

Who this might be right for
Colorectal Cancer Metastatic
European Organisation for Research and Treatment of Cancer - EORTC 5
Testing effectiveness (Phase 2)Ended earlyNCT01004159
What this trial is testing

Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT01186705
What this trial is testing

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01836653
What this trial is testing

Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Who this might be right for
Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer
EPS Corporation 122
Not applicableWithdrawnNCT01631539
What this trial is testing

Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC

Who this might be right for
Liver MetastasesColorectal Cancer
Universitaire Ziekenhuizen KU Leuven
Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Testing effectiveness (Phase 2)Study completedNCT00803647
What this trial is testing

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Who this might be right for
Metastatic Colorectal Cancer
NSABP Foundation Inc 20
Testing effectiveness (Phase 2)Study completedNCT01652482
What this trial is testing

Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 135
Early research (Phase 1)Study completedNCT00879385
What this trial is testing

KRAS Wild-type Metastatic Colorectal Cancer Trial

Who this might be right for
Colorectal Cancer
University of Utah 21
Testing effectiveness (Phase 2)UnknownNCT01322178
What this trial is testing

Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 90
Not applicableStudy completedNCT01082315
What this trial is testing

A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment

Who this might be right for
Colorectal Neoplasms
Merck KGaA, Darmstadt, Germany 730
Testing effectiveness (Phase 2)Study completedNCT02295930
What this trial is testing

Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 143
Early research (Phase 1)Study completedNCT01451632
What this trial is testing

A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

Who this might be right for
Colorectal CancerSquamous Cell Head and Neck CancerNon-small Cell Lung Cancer+2 more
Merrimack Pharmaceuticals 48
Not applicableStudy completedNCT00853931
What this trial is testing

Biomarker - Panitumumab Response With KRAS Wild Type MCC

Who this might be right for
Metastatic Colorectal Cancer
British Columbia Cancer Agency 52
Next Page